The House health committee on Thursday called for an emergency session to examine obstacles in the approval process for oncology drugs, formally registering the issue on its agenda . The move comes amid rising complaints from doctors and patients about critical delays.
Committee chair and Disy MP, Efthymios Diplaros, said the delays followed the recent transfer of the special drugs committee from the ministry of health to the health insurance
